Clear Street’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Clear Street’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-104,246	Closed	-$31.3K	–	960
2023 Q4	$31.3K	Buy	104,246 +4,845	+5%	+$1.5K	﹤0.01%	220
2023 Q3	$34.7K	Sell	99,401 -299	-0.3%	-$79	﹤0.01%	302
2023 Q2	$16K	Buy	+99,700	New	+$16.3K	﹤0.01%	618
2023 Q1	–	Sell	-377,501	Closed	-$23K	–	1342
2022 Q4	$23K	Hold	377,501	–	–	﹤0.01%	361
2022 Q3	$15K	Buy	+377,501	New	+$41.7K	﹤0.01%	532

Clear Street's DMAQR Position: Q1 2024 in Review

Clear Street sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 104,246 shares — an estimated $31.3K sold.

Clear Street first reported a position in DMAQR in Q3 2022 and held it in 5 quarters. The position peaked at $34.7K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Clear Street reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Clear Street sold 104,246 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $31.3K.
Clear Street first reported a position in Deep Medicine Acquisition Corp. Rights in Q3 2022 and held it in 5 quarters.
Clear Street's Deep Medicine Acquisition Corp. Rights position peaked at $34.7K in Q3 2023.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Clear Street's 13F filing for Q1 2024, filed 13 May 2024.